NCT03730441

Brief Summary

The aim of the study is to compare ADR for colonoscopies from various indications and to find correlations between ADR of screening and all examinations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6,925

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

November 2, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 5, 2018

Completed
Last Updated

November 5, 2018

Status Verified

November 1, 2018

Enrollment Period

4.9 years

First QC Date

November 2, 2018

Last Update Submit

November 2, 2018

Conditions

Colon Neoplasm

Outcome Measures

Primary Outcomes (1)

  • correlation between ADR of screening and all colonoscopies (screening, surveillance, diagnostic)

    Pearson´s correlation coefficient

    january 2013 - december 2017

Interventions

ColonoscopyDEVICE

Endoscopic examination of large bowel

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

people over 50 years of age coming for colonoscopic examination

You may qualify if:

  • people over 50 years of age coming for colonoscopic examination (screening, surveillance, diagnostic)

You may not qualify if:

  • age under 50 years
  • indication for colonoscopy: therapeutic, IBD, management of complications and sigmoidoscopies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Frydek-Mistek

Frýdek-Místek, Czechia

Location

Related Publications (1)

  • Mikoviny Kajzrlikova I, Vitek P, Chalupa J, Kuchar J, Platos J, Reha P, Klvana P. Correlation between ADR of screening and all colonoscopies. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021 Nov;165(4):386-389. doi: 10.5507/bp.2020.059. Epub 2020 Dec 16.

    PMID: 33325459DERIVED

MeSH Terms

Conditions

Colonic Neoplasms

Interventions

Colonoscopy

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Ivana Mikoviny Kajzrlikova

    Doctor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

November 2, 2018

First Posted

November 5, 2018

Study Start

January 1, 2013

Primary Completion

December 1, 2017

Study Completion

December 1, 2017

Last Updated

November 5, 2018

Record last verified: 2018-11

Locations

CZ(1)